摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

腾毒素 | 28540-82-1

中文名称
腾毒素
中文别名
——
英文名称
tentoxin
英文别名
(3S,6S,12Z)-12-benzylidene-1,6,7-trimethyl-3-(2-methylpropyl)-1,4,7,10-tetrazacyclododecane-2,5,8,11-tetrone
腾毒素化学式
CAS
28540-82-1;64070-01-5;65452-16-6
化学式
C22H30N4O4
mdl
——
分子量
414.505
InChiKey
SIIRBDOFKDACOK-LFXZBHHUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >174°C (dec.)
  • 溶解度:
    氯仿(微溶)、DMSO(微溶)、甲醇(微溶、超声处理)
  • 碰撞截面:
    202 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine]

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    30
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    98.8
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • WGK Germany:
    3
  • 海关编码:
    29337900

SDS

SDS:8d40c1b78a2d0f1a459933155f4d68c2
查看

制备方法与用途

生物活性方面,tentoxin 是一种从细交链孢菌中提取的环状四肽。作为一种除草剂,它能够抑制循环光合磷酸化和能量传递,从而导致幼苗枯黄。

反应信息

  • 作为反应物:
    描述:
    腾毒素甲醇 为溶剂, 反应 2.5h, 生成 tentoxin
    参考文献:
    名称:
    Isotentoxin, a conversion product of the phytotoxin tentoxin
    摘要:
    Isotentoxin, the E-isomer of the phytotoxin tentoxin, can be produced from tentoxin by UV irradiation. A clean separation of both cyclopeptides is possible using adsorption chromatography on Sephadex G-15. Since artificial daylight causes an inter-conversion of both compounds, special care should be taken in consideration for the interpretation of the chlorosis bioassays. Indeed, isotentoxin seems to have no chlorosis activity, but has stronger wilting effects than tentoxin against the problem weed Galium aparine L.
    DOI:
    10.1016/0031-9422(96)00194-x
  • 作为产物:
    描述:
    参考文献:
    名称:
    Tentoxin as a Scaffold for Drug Discovery. Total Solid-Phase Synthesis of Tentoxin and a Library of Analogues
    摘要:
    [GRAPHICS]A solid-phase method for the synthesis of tentoxin has been developed. Two key steps-dehydration and Malkylation-are carried out while the peptide is anchored to the resin. The method, which has been validated by the preparation of a library of tentoxin analogues, should be applicable to the generation of further libraries that have the tentoxin scaffold structure, as well as other structures containing N-alkylated didehydroamino acids.
    DOI:
    10.1021/ol0345273
点击查看最新优质反应信息

文献信息

  • MUCOUS LAYER-ADHESIVE POLY-r-GLUTAMIC ACID NANOMICELLES AND DRUG DELIVERY SYSTEM USING SAME
    申请人:BIOLEADERS CORPORATION
    公开号:US20160193348A1
    公开(公告)日:2016-07-07
    The present invention relates to nanomicelles composed of a complex of a lipophilic compound and a poly-gamma-glutamic acid wherein a portion of carboxyl groups are substituted with an amine group, and more particularly, to nanomicelles composed of a complex of a lipophilic compound and a poly-gamma-glutamic acid wherein a portion of carboxyl groups are substituted with an amine group, a preparation method thereof, and a drug delivery system employing the mucous membrane-adhesive property of the nanomicelles. According to the present invention, the nanomicelle drug delivery system based on poly-gamma-glutamic acid that is a natural biopolymer can be used for the delivery of a drug to mucous membranes to thereby increase the in vivo stability and effectiveness of the drug.
    本发明涉及由脂溶性化合物和聚γ-谷氨酸复合物组成的纳米胶束,其中部分羧基被胺基取代,更具体地,涉及由脂溶性化合物和聚γ-谷氨酸复合物组成的纳米胶束,其中部分羧基被胺基取代,以及其制备方法和利用纳米胶束的粘膜粘附性质的药物传递系统。根据本发明,基于天然生物聚合物聚γ-谷氨酸的纳米胶束药物传递系统可用于将药物传递至粘膜,从而增加药物在体内的稳定性和有效性。
  • New synthesis of the cyclic tetrapeptide tentoxin employing an azlactone as key intermediate
    作者:Florine Cavelier、Jean Verducci
    DOI:10.1016/0040-4039(95)00762-2
    日期:1995.6
    An improved preparation of the cyclic tetrapeptide Tentoxin is reported employing an azlactone as key intermediate. This new synthetic route offers the advantage over existing methodologies that the dehydro amino acid would easily be varied, thus allowing the simple preparation of analogues.
    据报道,使用a内酯作为关键中间体,改进了环状四肽肌腱毒素的制备。这种新的合成路线提供了优于现有方法的优点,即脱氢氨基酸很容易被改变,从而允许类似物的简单制备。
  • Präparat zur Wirkstoffapplikation in Kleinsttröpfchenform
    申请人:Cevc, Gregor, Prof. Dr.
    公开号:EP0475160A1
    公开(公告)日:1992-03-18
    Die Erfindung betrifft ein Präparat zur Applikation von Wirkstoffen in Form kleinster, insbesondere mit einer membranartigen Hülle aus einer oder wenigen Lagen amphiphiler Moleküle bzw. mit einer amphiphilen Trägersubstanz versehenen Flüssigkeitströpfchen, insbesondere zum Transport des Wirkstoffes in und durch natürliche Barrieren und Konstriktionen wie Häute und dergleichen. Das Präparat weist einen Gehalt einer randaktiven Substanz auf, der bis zu 99 Mol.-% des Gehaltes dieser Substanz entspricht, durch den der Solubilisierungspunkt der Tröpfchen erreicht wird. Das Präparat eignet sich zur nichtinvasiven Verabreichung von Antidiabetica, insbesondere von Insulin. Die Erfindung betrifft außerdem ein Verfahren zur Herstellung solcher Präparate.
    本发明涉及一种以微小液滴形式施用活性物质的制剂,特别是具有一层或几层两亲性分子或两亲性载体物质的膜状包膜,尤其是用于将活性物质输送到或通过皮肤等天然屏障和收缩物。制剂中边缘活性物质的含量最高可达 99 摩尔%,从而达到液滴的溶解点。该制剂适用于非侵入性给药抗糖尿病药物,特别是胰岛素。本发明还涉及生产这种制剂的工艺。
  • BIOLOGICAL CONTROL OF WEEDS USING THE METABOLITES OF ALTERNARIA ALTERNATA
    申请人:Nanjing Agricultural University
    公开号:EP1849361A1
    公开(公告)日:2007-10-31
    This invention teaches a method of controlling weeds using the metabolites tenuazonic acid, iso-tenuazonic acid and their salts isolated from the cultures of Alternaria alternata (Fr.) Keissler. Spraying of any of these compounds at a concentration of 5 to 800 µg/g can cause main broad leaf, grassy and sedge weeds to hurt, wilt, and dry to death. Tenuazonic acid, iso-tenuazonic acid, and their salts exhibit herbicidal activity with broad spectrum, quick killing, and high efficiency. The addition of adjuvants improves the herbicidal activity of these compounds.
    本发明传授了一种使用从 Alternaria alternata (Fr.) Keissler 的培养物中分离出的代谢物tenuazonic 酸、异tenuazonic 酸及其盐类来控制杂草的方法。喷洒浓度为 5 至 800 µg/g 的这些化合物,可使主要阔叶杂草、禾本科杂草和莎草受伤、枯萎和干枯死亡。噻努唑啉酸、异噻努唑啉酸及其盐类具有广谱、速效、高效的除草活性。添加佐剂可提高这些化合物的除草活性。
  • Method for improving the crop of laticiferous plants
    申请人:Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    公开号:EP2055782A1
    公开(公告)日:2009-05-06
    The present invention broadly relates to the field of agronomy. In particular, the present invention is directed to methods specifically designed to improve the crop of laticiferous plants or parts thereof. According to one basic principle of the invention, it was found that a major component of the latex protein of the laticiferous Taraxacum species is represented by a polyphenoloxidase (PPO) and that latex polymerisation depends predominantly on polyphenoloxidase (PPO) activity. Indeed, a comparison of latex flow and the presence of a PPO revealed that latex exhibiting strong PPO activity polymerises rapidly, whereas reduced PPO activity results in a sequential reduction or delay of latex polymerisation. On the basis of these findings, genetically modified dandelion plants were established that showed down-regulation of the PPO activity via RNA interference resulting in a strong delay in latex polymerisation. Thus and in accordance with the present invention, there is provided a method for improving the crop of latex from laticiferous plants or parts thereof, wherein the improvement consists in using laticiferous plants or parts thereof in which the latex-specific polyphenoloxidase activity, as compared to the respective wild-type or untreated plant or part thereof, is significantly reduced or eliminated. Furthermore, there are provided genetically modified laticiferous plants and parts thereof showing reduced or eliminated latex-specific polyphenoloxidase activity.
    本发明广泛涉及农学领域。特别是,本发明涉及专门用于改良石蒜科植物或其部分作物的方法。 根据本发明的一个基本原理,研究人员发现,多叶植物 Taraxacum 种类的乳胶蛋白的主要成分是多酚氧化酶 (PPO),而乳胶的聚合主要取决于多酚氧化酶 (PPO) 的活性。事实上,通过比较乳胶的流动性和 PPO 的存在,可以发现 PPO 活性强的乳胶聚合速度快,而 PPO 活性弱的乳胶聚合速度会逐渐减慢或延迟。根据这些研究结果,建立了转基因蒲公英植物,该植物通过 RNA 干扰下调 PPO 活性,导致胶乳聚合的强烈延迟。 因此,根据本发明,提供了一种用于改善有叶植物或其部分的胶乳作物的方法,其中的改进包括使用有叶植物或其部分,与相应的野生型或未经处理的植物或其部分相比,其中的胶乳特异性多酚氧化酶活性显著降低或消失。 此外,还提供了转基因叶菜类植物及其部分,它们显示出乳胶特异性多酚氧化酶活性降低或消失。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物